These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6321068)

  • 1. Circulating digitalis-like compounds in essential hypertension.
    Devynck MA; Pernollet MG; Cloix JF; de The H; Kamal L; Elghozi JL; Rosenfeld J; Meyer P
    Clin Exp Hypertens A; 1984; 6(1-2):441-53. PubMed ID: 6321068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endogenous sodium pump inhibitor in essential hypertension.
    Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
    J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma digitalis-like activity and cytosolic Ca2+ in essential hypertension.
    Le Quan Sang KH; Pernollet MG; Meyer P; Devynck MA
    Am J Hypertens; 1990 Mar; 3(3):171-5. PubMed ID: 2157464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating inhibitor of the Na+-K+ pump in essential hypertension. Physiological and pharmacological variations].
    Pernollet MG; de Thé H; Delva P; Wauquier I; Devynck MA; Baudouin-Legros M; Deray G; Rosenfeld J; Meyer P
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1283-7. PubMed ID: 6098238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma digitalislike activity in essential hypertension or end-stage renal disease.
    Deray G; Pernollet MG; Devynck MA; Zingraff J; Touam A; Rosenfeld J; Meyer P
    Hypertension; 1986 Jul; 8(7):632-8. PubMed ID: 3013777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of digitalis-like compound in plasma: application in studies of essential hypertension.
    Devynck MA; Pernollet MG; Rosenfeld JB; Meyer P
    Br Med J (Clin Res Ed); 1983 Sep; 287(6393):631-4. PubMed ID: 6309318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance.
    Goto A; Yamada K; Ishii M; Sugimoto T
    Am J Med; 1990 Oct; 89(4):420-6. PubMed ID: 2220875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic hypertension in the SHR rat and circulating digitalis compounds].
    Wauquier I; Pernollet MG; Grichois ML; Meyer P; Devynck MA
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):982-6. PubMed ID: 2821951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous inhibitors of the Na+, K(+)-pump and platelet Ca2+ handling in hypertension.
    Devynck MA; David-Dufilho M; Astarie C; Mazeaud M; Pernollet MG; Le Quan Sang KH
    Physiol Bohemoslov; 1990; 39(1):71-8. PubMed ID: 2165268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet 5-HT content and uptake in essential hypertension: role of endogenous digitalis-like factors and plasma cholesterol.
    Guicheney P; Devynck MA; Cloix JF; Pernollet MG; Grichois ML; Meyer P
    J Hypertens; 1988 Nov; 6(11):873-9. PubMed ID: 2853193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma sodium pump inhibitor in essential hypertension and normotensive subjects with hypertensive heredity.
    de Thé H; Devynck MA; Rosenfeld J; Pernollet MG; Elghozi JL; Meyer P
    J Cardiovasc Pharmacol; 1984; 6 Suppl 1():S49-54. PubMed ID: 6204159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Circulating inhibitor of sodium active transport in essential hypertension and volemic expansion].
    Devynck MA; Pernollet MG; Deray G; Rieu M; Meyer P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1691-5. PubMed ID: 3006621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenous digitalis-like compound extracted from human urine: biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Meyer P
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1522-7. PubMed ID: 2825938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the endogenous Na+-pump inhibitor in essential hypertension and blood volume expansion.
    Devynck MA; Pernollet MG; Deray G; Wauquier I; Delva P; Rieu M; Henning G; Cloix JF; Crabos M; Baudouin-Legros M
    J Hypertens Suppl; 1984 Dec; 2(3):S453-5. PubMed ID: 6100747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating digitalis-like substance is increased in DOCA-salt hypertension.
    Kojima I
    Biochem Biophys Res Commun; 1984 Jul; 122(1):129-36. PubMed ID: 6331439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]serotonin uptake in human blood platelets is reduced by ouabain and endogenous digitalis-like inhibitors of Na+, K+-ATPase.
    Kamal LA; Cloix JF; Devynck MA; Meyer P
    Eur J Pharmacol; 1983 Aug; 92(1-2):167-8. PubMed ID: 6313389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.